NEW! Cost Savings Calculator

See how much you could save by prescribing Trustsaver® products

Thorens® 25,000 I.U. Capsule, hard, 12 Pack

(colecalciferol)

20% savings with Thorens® 25,000 I.U. Capsule, hard, 12  vs Stexerol-D3 25,000 I.U. tablets, 121

Contact us today
Thorens® 25,000 I.U. Capsule, hard, 12

Indicated for the initial treatment of clinically relevant vitamin D deficiency in adults2

Suitable for at-risk groups3

  • The elderly (>65 years)

  • People who are housebound

  • People with darker skin

  • People who cover their skin for cultural reasons

Thorens® 25,000 I.U. Capsules, Hard

  • The Royal Osteoporosis Society recommends an adult loading regimen up to a total of approximately 300,000 units given as weekly or daily split doses*4

  • Thorens® meets the Royal Osteoporosis Society loading dose recommendations for the treatment of vitamin D deficiency in adults†

Make significant drug acquisition cost savings vs. Stexerol-D3 25,000 I.U tablets, 12 by prescribing Thorens® 25,000 I.U. Capsules, Hard, 12 by brand

Get personalised savings
Assumptions and Calculations References Prescribing Information
Assumptions and Calculations

  • Potential savings with Thorens® 25,000 I.U. Capsule, hard are based on the MIMS list price of Stexerol-D3 25,000 I.U. tablets and have been calculated based on cost per pack.1

  • The NHS list price of Thorens® 25,000 I.U. Capsule, hard is £13.60 per unit (12 pack), and the NHS list price of Stexerol-D3 25,000 I.U. tablets is £17.00 per unit (12 pack).

References

  1. MIMS Online. Accessed December 2020.

  2. Thorens® 25,000 I.U. Capsule, hard. Summary of Product Characteristics. June 2020.

  3. NICE. Vitamin D: increasing supplement use among at-risk groups. NICE public health guidance 56. November 2014 (updated August 2017).

  4. Royal Osteoporosis Society. Vitamin D and Bone Health: A Practical Guideline for Patient Management. December 2018

Prescribing Information

* Please note: the Royal Osteoporosis Society recommendations do not cover pregnant women or those with severe or end-stage chronic kidney disease.

† Based on taking 2 x 25,000 I.U. capsules per week for 6 weeks as per national dosing guidelines.4 

 

Stexerol-D3 25,000 I.U. tablets is a registered trademark of Kyowa Kirin Ltd.

Request personalised potential savings

Provide a few quick details and we'll get back to you with the savings your organisation could make with Trustsaver®

Galen will not share your email address with any third parties. By requesting information you are under no obligation to meet with a Galen representative. By submitting your information you acknowledge that you have read the Galen privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to customer.services@galen-pharma.com. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.

By using this website, you agree to the use of cookies as described in our Privacy Policy.

Accept

Designed to help prescribing budgets go further

I am a Healthcare Professional
I am a Patient
The Trustsaver® portfolio of products includes:
  • Dermipar® Ointment (ingredients include white soft paraffin, liquid paraffin, cetomacrogol emulsifying wax)
  • ExoCream® (ingredients include white soft paraffin 14.5% w/w, liquid paraffin 12.6% w/w and anhydrous lanolin 1.0% w/w)
  • Laxido® Orange (macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride)
  • Laxido® Paediatric Plain (macrogol 3350, sodium chloride, sodium hydrogen carbonate, potassium chloride)
  • Miclaro™ Oat Cream (ingredients include avena sativa kernel flour 1% w/w)
  • Miclaro™ Oat Lotion (ingredients include avena sativa kernel flour 1% w/w)
  • MyriBase™ Emollient Shower Gel (ingredients include isopropyl myristate 15% w/w and liquid paraffin 15% w/w)
  • MyriBase™ Gel (ingredients include isopropyl myristate 15% w/w and liquid paraffin 15% w/w)
  • Rapilose® Gel (glucose gel 40% w/w)
  • Salivix® Plus (ingredients include malic acid and sodium fluoride)
  • Salivix® Spray (ingredients include malic acid, xylitol and sodium fluoride)
  • Thorens® 10,000 I.U./ml oral drops, solution (colecalciferol)
  • Thorens® 25,000 I.U./2.5ml oral solution (colecalciferol)
  • Thorens® 25,000 I.U. Capsule, hard, 3 Pack (colecalciferol)
  • Thorens® 25,000 I.U. Capsule, hard, 12 Pack (colecalciferol)
  • Zemtard® XL (diltiazem hydrochloride)

Patient Information

Galen Limited is a privately-owned pharmaceutical sales and marketing company established in 1968. By combining innovation in product development with competitive pricing, Galen aims to work in partnership with healthcare professionals and patients, a major factor in the company's success to date. If you would like to find out more about Galen, its products or information on the disease areas we cover, please visit www.galen-pharma.com.